Latest Ratios: P/E Ratio 9.8x · EV/EBITDA 6.5x · ROE 14.0%. (1989–2025 historical series)
Price-based multiples — how expensive the stock is relative to earnings, sales, book value, and cash flow
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $9.7B | — | — | — | — | — | — | — | — | — | — |
| Enterprise Value | $10.5B | — | — | — | — | — | — | — | — | — | — |
| P/E Ratio → | 9.78 | — | — | — | — | — | — | — | — | — | — |
| P/S Ratio | 0.62 | — | — | — | — | — | — | — | — | — | — |
| P/B Ratio | 1.36 | 1.29 | — | — | — | — | — | — | — | — | — |
| P/FCF | 13.44 | — | — | — | — | — | — | — | — | — | — |
| P/OCF | 9.11 | — | — | — | — | — | — | — | — | — | — |
P/E links to full P/E history page with 30-year chart
Enterprise-value multiples — capital-structure-neutral measures of total business value
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| EV / Revenue | — | — | — | — | — | — | — | — | — | — | — |
| EV / EBITDA | 6.47 | — | — | — | — | — | — | — | — | — | — |
| EV / EBIT | 12.49 | — | — | — | — | — | — | — | — | — | — |
| EV / FCF | — | — | — | — | — | — | — | — | — | — | — |
Margins and return-on-capital ratios measuring operating efficiency
Full margin charts and quarterly trend are on the Earnings History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross Margin | 13.5% | — | 13.4% | 6.1% | 9.2% | 12.2% | 11.8% | 10.0% | 11.8% | 14.0% | 6.5% |
| Operating Margin | 8.3% | — | 7.9% | -0.4% | 6.9% | 5.5% | 6.2% | 3.9% | 5.5% | 9.0% | 0.6% |
| Net Profit Margin | 6.4% | — | 6.7% | 0.1% | 5.4% | 3.1% | 3.7% | 1.4% | 2.8% | 4.3% | -0.9% |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ROE | 14.0% | — | 14.1% | 0.2% | 14.0% | 9.6% | 14.4% | 5.7% | 10.4% | 16.5% | -3.8% |
| ROA | 8.1% | — | 7.8% | 0.1% | 7.3% | 4.5% | 6.2% | 2.4% | 4.8% | 6.8% | -1.4% |
| ROIC | 12.2% | 8.2% | 10.0% | -0.4% | 10.5% | 8.9% | 11.5% | 7.5% | 10.5% | 15.5% | 0.9% |
| ROCE | 12.4% | 8.5% | 11.1% | -0.5% | 11.4% | 9.3% | 12.7% | 8.5% | 11.4% | 17.0% | 1.0% |
Solvency and debt-coverage ratios — lower is generally safer
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Debt / Equity | 0.34 | 0.34 | 0.39 | 0.33 | 0.33 | 0.47 | 0.59 | 0.81 | 0.58 | 0.60 | 1.09 |
| Debt / EBITDA | 1.48 | 2.03 | 1.62 | 6.64 | 1.59 | 2.23 | 2.35 | 3.30 | 2.03 | 1.60 | 9.86 |
| Net Debt / Equity | — | 0.12 | 0.23 | 0.24 | 0.25 | 0.32 | 0.50 | 0.71 | 0.48 | 0.49 | 0.93 |
| Net Debt / EBITDA | 0.53 | 0.73 | 0.97 | 4.79 | 1.23 | 1.54 | 1.97 | 2.89 | 1.70 | 1.32 | 8.38 |
| Debt / FCF | — | 1.19 | 1.80 | 2.81 | 10.74 | 3.75 | 4.48 | — | 5.87 | 3.98 | 30.62 |
| Interest Coverage | 31.98 | 15.87 | 17.08 | -0.70 | 13.03 | 5.84 | 5.85 | 2.36 | 4.02 | 4.09 | 0.19 |
Short-term solvency ratios and asset-utilisation metrics
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Current Ratio | 2.97 | 2.97 | 2.46 | 2.01 | 2.14 | 2.42 | 2.55 | 2.03 | 2.90 | 2.72 | 2.79 |
| Quick Ratio | 1.63 | 1.63 | 1.05 | 0.97 | 1.01 | 1.06 | 1.05 | 0.69 | 1.08 | 1.07 | 1.23 |
| Cash Ratio | 0.88 | 0.88 | 0.55 | 0.28 | 0.21 | 0.46 | 0.30 | 0.18 | 0.29 | 0.31 | 0.38 |
| Asset Turnover | — | — | 1.28 | 1.10 | 1.17 | 1.46 | 1.48 | 1.71 | 1.76 | 1.60 | 1.45 |
| Inventory Turnover | 5.77 | — | 5.08 | 5.42 | 5.01 | 6.04 | 6.01 | 5.07 | 5.57 | 5.19 | 5.63 |
| Days Sales Outstanding | — | — | 14.40 | 14.39 | 17.03 | 19.21 | 20.98 | 18.31 | 17.41 | 21.23 | 20.25 |
Earnings, FCF, buyback, and dividend yields — total returns to shareholders
Full dividend history and growth charts are on the Dividend History page
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dividend Yield | 4.1% | 4.4% | — | — | — | — | — | — | — | — | — |
| Payout Ratio | 40.1% | — | 30.2% | 1900.0% | 57.0% | 6.6% | — | — | — | — | — |
| Metric | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2015 | FY 2014 | FY 2012 | FY 2011 | FY 2010 | FY 2009 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Earnings Yield | 10.2% | — | — | — | — | — | — | — | — | — | — |
| FCF Yield | 7.4% | — | — | — | — | — | — | — | — | — | — |
| Buyback Yield | 0.0% | — | — | — | — | — | — | — | — | — | — |
| Total Shareholder Yield | 4.1% | — | — | — | — | — | — | — | — | — | — |
| Shares Outstanding | — | $0 | $380M | $393M | $380M | $380M | $380M | $146M | $164M | $167M | $157M |
Commodity Input Cost Volatility
Based on current market data, Smithfield Foods trades at a 10.01x P/E ratio, which appears to reflect a significant discount relative to peers like Hormel Foods, suggesting that investors are pricing in the inherent volatility of its commodity-heavy, vertically integrated agricultural business model.
The forward P/E of 9.46 indicates that the market expects limited earnings expansion, likely due to the cyclical nature of pork production and potential geopolitical headwinds. This valuation multiple suggests that the market views the company more as a commodity processor than a high-margin branded consumer goods firm.
According to recent financial statements, Smithfield's ROIC has fluctuated between 1.5% and 4.1% over the last ten quarters, indicating that the company struggles to consistently generate returns that meaningfully exceed its cost of capital in a highly capital-intensive, asset-heavy agricultural environment.
The low ROIC trend suggests that the massive infrastructure required for vertical integration acts as a drag on capital efficiency. Investors should monitor whether management can improve these returns through higher-margin bioscience initiatives or if the asset-heavy nature of the business will continue to suppress long-term compounding.
As reported in historical filings, the company's cash conversion cycle has oscillated between 60 and 81 days, highlighting the significant operational challenges in managing inventory and trade payables within a complex, multi-stage protein supply chain that is highly sensitive to external market conditions.
The variability in the cash conversion cycle suggests that Smithfield's liquidity is frequently tied up in inventory, which may be exacerbated by the need to balance production throughput with fluctuating export demand. This inefficiency warrants further investigation into the company's ability to optimize its working capital during periods of commodity price stress.
Based on the provided data, Smithfield maintains a disciplined debt-to-equity ratio of 0.33 as of 2026Q1, which appears to provide a substantial buffer against interest rate volatility and supports the company's ability to navigate cyclical downturns without facing immediate refinancing or covenant risks.
The consistent interest coverage ratio, which has remained largely positive despite sector-wide volatility, suggests that the company's debt service remains comfortable. This conservative capital structure is a key differentiator, though it may also reflect the parent company's specific approach to intercompany financing rather than pure market-based leverage.
The P/E ratio is frequently misapplied to Smithfield Foods, as it obscures the significant non-cash gains and losses associated with biological asset valuations and commodity hedging, which can artificially inflate or deflate earnings in any given quarter, leading to a distorted view of operational health.
Analysts should instead prioritize EV/EBITDA or normalized free cash flow metrics to better assess the company's underlying earning power. Relying solely on P/E ignores the structural reality that this business is a logistics and genetics operation, not just a standard consumer packaged goods manufacturer.
Includes 30+ ratios · 30 years · Updated daily
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.
Quick answers to the most common questions about buying SFD stock.
Smithfield Foods, Inc.'s current P/E ratio is 9.8x. This places it at the 50th percentile of its historical range.
Smithfield Foods, Inc.'s current EV/EBITDA is 6.5x. This enterprise value multiple compares the company's total value (equity + debt - cash) to its EBITDA.
Smithfield Foods, Inc.'s return on equity (ROE) is 14.0%. The historical average is 12.2%.
Based on historical data, Smithfield Foods, Inc. is trading at a P/E of 9.8x. This is at the 50th percentile of its historical P/E range. Compare with industry peers and growth rates for a complete picture.
Smithfield Foods, Inc.'s current dividend yield is 4.11% with a payout ratio of 40.1%.
Smithfield Foods, Inc. has 13.5% gross margin and 8.3% operating margin.
Smithfield Foods, Inc.'s Debt/EBITDA ratio is 1.5x, indicating moderate leverage. A ratio below 2x is generally considered financially healthy.